We are live on ! Find out more
RCM

Revelation Capital Management Portfolio holdings

AUM $67.4M
This Fund
S&P 500
This Quarter Est. Return
-39.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26M
AUM Growth
-$2.81M
Cap. Flow
+$344K
Cap. Flow %
8.08%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
AKLI
Akili Inc
AKLI
+$1.76M

Top Sells

Rank Stock Value
1
NPCE icon
Neuropace
NPCE
+$989K
2
ACCD
Accolade Inc
ACCD
+$430K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMIC
1
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$3.54M 83.16%
47,195
– –
AKLI
2
DELISTED
Akili Inc
AKLI
$556K 13.06%
+245,912
New +$1.76M
NPCE icon
3
Neuropace
NPCE
$522M
$161K 3.78%
42,972
-205,155
-83% -$989K
ACCD
4
DELISTED
Accolade Inc
ACCD
– –
-58,050
Closed -$430K

Similar funds

RC
Rithm Capital New York $67.4M AUM 37.43% 1-Year Est. Return
MA
Mosaic Advisors Houston, Texas $66.8M AUM 23.34% 1-Year Est. Return
S4W
Solutions 4 Wealth Southlake, Texas $66.5M AUM 10.15% 1-Year Est. Return
SGOM
SIP Global Opportunity Manager Portsmouth, New Hampshire $66.3M AUM
VIM
VCU Investment Management Richmond, Virginia $68.6M AUM
ILCM
Ivy Lane Capital Management Winter Park, Florida $66.1M AUM 28.52% 1-Year Est. Return
FWA
Fidelis Wealth Advisors Castle Rock, Colorado $68.7M AUM
EVC
Emeth Value Capital New Orleans, Louisiana $66M AUM 35.55% 1-Year Est. Return

Revelation Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Revelation Capital Management held 4 positions worth $4.26M, down 40% from $7.07M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Revelation Capital Management deployed $344K of net new capital in Q3 2022, opening 1 new position. Its largest new stake was Akili Inc: 245,912 shares worth $556K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 94% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Neuropace, an estimated $989K trimmed.

  • Revelation Capital Management's largest Q3 2022 buy was Akili Inc: 245,912 shares worth $556K.
  • Revelation Capital Management's biggest Q3 2022 reduction was Neuropace, cutting an estimated $989K.
  • Revelation Capital Management fully exited Accolade Inc in Q3 2022, selling an estimated $430K.
  • Revelation Capital Management's ten largest holdings make up 100% of its $4.26M portfolio in Q3 2022.
  • Revelation Capital Management opened 1 new position and closed 1 in Q3 2022.
  • Revelation Capital Management's portfolio value fell 40% quarter-over-quarter to $4.26M.

Based on Revelation Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.